T4N5 liposome lotion

Drug Profile

T4N5 liposome lotion

Alternative Names: Dimericine; Liposome encapsulated T4 endonuclease V; T4N5

Latest Information Update: 16 Nov 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Applied Genetics Inc Dermatics
  • Class Antineoplastics; Endodeoxyribonucleases; Skin disorder therapies
  • Mechanism of Action DNA repair enzyme replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Xeroderma pigmentosum

Highest Development Phases

  • Discontinued Skin cancer; Xeroderma pigmentosum

Most Recent Events

  • 19 Aug 2009 Discontinued - Phase-II for Skin cancer in USA (Topical)
  • 19 Aug 2009 Discontinued - Phase-III for Xeroderma pigmentosum in USA (Topical)
  • 30 Aug 2007 T4N5 liposome lotion received Fast Track designation for Xeroderma pigmentosum in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top